1. Home
  2. ZLAB vs MLCO Comparison

ZLAB vs MLCO Comparison

Compare ZLAB & MLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$26.25

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Melco Resorts & Entertainment Limited

MLCO

Melco Resorts & Entertainment Limited

HOLD

Current Price

$5.19

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
MLCO
Founded
2013
2003
Country
China
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
ZLAB
MLCO
Price
$26.25
$5.19
Analyst Decision
Strong Buy
Buy
Analyst Count
5
5
Target Price
$49.60
$10.10
AVG Volume (30 Days)
1.2M
1.4M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
38.46
N/A
EPS
N/A
N/A
Revenue
$460,156,000.00
N/A
Revenue This Year
$9.75
$5.42
Revenue Next Year
$26.03
$4.37
P/E Ratio
N/A
$12.16
Revenue Growth
15.33
N/A
52 Week Low
$15.96
$4.99
52 Week High
$34.72
$9.98

Technical Indicators

Market Signals
Indicator
ZLAB
MLCO
Relative Strength Index (RSI) 60.90 42.16
Support Level $16.98 $5.13
Resistance Level $27.08 $5.73
Average True Range (ATR) 0.84 0.15
MACD -0.19 -0.02
Stochastic Oscillator 53.72 35.19

Price Performance

Historical Comparison
ZLAB
MLCO

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About MLCO Melco Resorts & Entertainment Limited

Melco Resorts & Entertainment is one of only six licensed casino operators in Macao. It operates Altira, a complex focused on premium customers; City of Dreams, an integrated resort in Cotai serving both mass-market and premium patrons; and Mocha Clubs' electronic gaming machines. The company also has a majority interest in Studio City, which opened in 2015. Outside Macao, Melco owns City of Dreams Manila in the Philippines and City of Dreams Mediterranean in Cyprus. The business mix in terms of adjusted EBITDA was about 84% from Macao, with the rest from overseas as of 2025.

Share on Social Networks: